513 related articles for article (PubMed ID: 23044265)
1. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.
Sultana R; Perluigi M; Butterfield DA
Free Radic Biol Med; 2013 Sep; 62():157-169. PubMed ID: 23044265
[TBL] [Abstract][Full Text] [Related]
2. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.
Perluigi M; Coccia R; Butterfield DA
Antioxid Redox Signal; 2012 Dec; 17(11):1590-609. PubMed ID: 22114878
[TBL] [Abstract][Full Text] [Related]
3. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
Di Domenico F; Tramutola A; Butterfield DA
Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
[TBL] [Abstract][Full Text] [Related]
4. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
Butterfield DA; Bader Lange ML; Sultana R
Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
[TBL] [Abstract][Full Text] [Related]
5. High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner.
Long EK; Olson DM; Bernlohr DA
Free Radic Biol Med; 2013 Oct; 63():390-8. PubMed ID: 23726997
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological relevance of aldehydic protein modifications.
Zarkovic N; Cipak A; Jaganjac M; Borovic S; Zarkovic K
J Proteomics; 2013 Oct; 92():239-47. PubMed ID: 23438936
[TBL] [Abstract][Full Text] [Related]
7. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
Reed TT; Pierce WM; Markesbery WR; Butterfield DA
Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
[TBL] [Abstract][Full Text] [Related]
9. Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.
Di Domenico F; Pupo G; Tramutola A; Giorgi A; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2014 Jun; 71():270-280. PubMed ID: 24675226
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease.
Fukuda M; Kanou F; Shimada N; Sawabe M; Saito Y; Murayama S; Hashimoto M; Maruyama N; Ishigami A
Biomed Res; 2009 Aug; 30(4):227-33. PubMed ID: 19729853
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical detection of lipid hydroperoxide- and aldehyde-modified proteins in diseases.
Sugiyama A; Sun J
Subcell Biochem; 2014; 77():115-25. PubMed ID: 24374923
[TBL] [Abstract][Full Text] [Related]
12. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
[TBL] [Abstract][Full Text] [Related]
13. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
Barone E; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
[TBL] [Abstract][Full Text] [Related]
14. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.
Hardas SS; Sultana R; Clark AM; Beckett TL; Szweda LI; Murphy MP; Butterfield DA
Redox Biol; 2013; 1(1):80-5. PubMed ID: 24024140
[TBL] [Abstract][Full Text] [Related]
15. Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells.
Maulucci G; Daniel B; Cohen O; Avrahami Y; Sasson S
Mol Aspects Med; 2016 Jun; 49():49-77. PubMed ID: 27012748
[TBL] [Abstract][Full Text] [Related]
16. Current status of acrolein as a lipid peroxidation product.
Uchida K
Trends Cardiovasc Med; 1999 Jul; 9(5):109-13. PubMed ID: 10639724
[TBL] [Abstract][Full Text] [Related]
17. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
[TBL] [Abstract][Full Text] [Related]
18. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
19. Isotope-coded dimethyl tagging for differential quantification of posttranslational protein carbonylation by 4-hydroxy-2-nonenal, an end-product of lipid peroxidation.
Rauniyar N; Prokai L
J Mass Spectrom; 2011 Oct; 46(10):976-85. PubMed ID: 22012663
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions.
Catalá A
Chem Phys Lipids; 2009 Jan; 157(1):1-11. PubMed ID: 18977338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
